On July 1, 2021, Truman Company acquired a 70 percent interest in Atlanta Company in exchange for consideration of $761,075 in cash and equity securities. The remaining 30 percent of Atlantas shares traded closely near an average price that totaled $326,175 both before and after Trumans acquisition.

In reviewing its acquisition, Truman assigned a $117,500 fair value to a patent recently developed by Atlanta, even though it was not recorded within the financial records of the subsidiary. This patent is anticipated to have a remaining life of five years.

The following financial information is available for these two companies for 2021. In addition, the subsidiarys income was earned uniformly throughout the year. The subsidiary declared dividends quarterly.

	Truman				Atlanta
Revenues	$	(757,375	)		$	(527,000	)
Operating expenses		472,000				376,000
Income of subsidiary		(44,625	)			0
Net income	$	(330,000	)		$	(151,000	)
Retained earnings, 1/1/21	$	(844,000	)		$	(533,000	)
Net income (above)		(330,000	)			(151,000	)
Dividends declared		145,000				60,000
Retained earnings, 12/31/21	$	(1,029,000	)		$	(624,000	)
Current assets	$	407,300			$	357,000
Investment in Atlanta		784,700				0
Land		452,000				267,000
Buildings		773,000				715,000
Total assets	$	2,417,000			$	1,339,000
Liabilities	$	(888,000	)		$	(395,000	)
Common stock		(95,000	)			(300,000	)
Additional paid-in capital		(405,000	)			(20,000	)
Retained earnings, 12/31/21		(1,029,000	)			(624,000	)
Total liabilities and stockholders' equity	$	(2,417,000	)		$	(1,339,000	)

1. What is the excess fair-value assigned to patent and goodwill?

2. How did Truman allocate the goodwill from the acquisition across the controlling and noncontrolling interests?

3. How did Truman derive the Investment in Atlanta account balance at the end of 2021?

4. Prepare a worksheet to consolidate the financial statements of these two companies as of December 31, 2021. At year-end, there were no intra-entity receivables or payables.